E-ISSN 2149-388X | ISSN 2149-0430
 

Case Report 


Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use

Sinan Tufekci, Hulya Halis.

Abstract
Introduction: Neonatal pulmonary hemorrhage (PH) is a clinical picture with various risk factors playing a role in its etiology and has a high neonatal mortality and morbidity rate. In this paper, we share the results of Ankaferd blood stopper (ABS) use in the treatment of neonatal PH.
Materials and methods: In this retrospective cross-sectional study, data were obtained using the patient file and automation systems. Two patients whose pulmonary bleeding was stopped by administering ABS between July 2018 and July 2020 in the neonatal intensive care unit were included in the study.
Results: The first patient was a male baby born by cesarean section at 38 3/7 weeks of gestation and weighing 3320 g. Massive PH was detected in the patient who developed cyanosis at the 3rd hour of maternal side follow-up. Despite endotracheal tube (ETT) aspiration, pulmonary bleeding continued, and the bleeding stopped immediately after ABS was used. The other patient was a male baby born by cesarean section at 33 6/7 weeks of gestation. Postpartum prematurity, respiratory distress syndrome, and neonatal sepsis were diagnosed and massive PH developed on the 9th day of follow-up. The bleeding stopped immediately after ABS was administered to the patient.
Conclusion: There is still no effective drug or method to treat PH in the neonatal period. ABS—a new treatment option—may be beneficial in reducing mortality and morbidity.

Key words: Ankaferd Blood Stopper (ABS), pulmonary hemorrhage treatment, neonate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sinan Tufekci
Articles by Hulya Halis
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Tufekci S, Halis H. Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. Ulutas Med J. 2021; 7(4): 248-253. doi:10.5455/umj.20210831071258


Web Style

Tufekci S, Halis H. Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. https://www.ulutasmedicaljournal.com/?mno=118157 [Access: April 05, 2022]. doi:10.5455/umj.20210831071258


AMA (American Medical Association) Style

Tufekci S, Halis H. Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. Ulutas Med J. 2021; 7(4): 248-253. doi:10.5455/umj.20210831071258



Vancouver/ICMJE Style

Tufekci S, Halis H. Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. Ulutas Med J. (2021), [cited April 05, 2022]; 7(4): 248-253. doi:10.5455/umj.20210831071258



Harvard Style

Tufekci, S. & Halis, . H. (2021) Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. Ulutas Med J, 7 (4), 248-253. doi:10.5455/umj.20210831071258



Turabian Style

Tufekci, Sinan, and Hulya Halis. 2021. Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. THE ULUTAS MEDICAL JOURNAL, 7 (4), 248-253. doi:10.5455/umj.20210831071258



Chicago Style

Tufekci, Sinan, and Hulya Halis. "Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use." THE ULUTAS MEDICAL JOURNAL 7 (2021), 248-253. doi:10.5455/umj.20210831071258



MLA (The Modern Language Association) Style

Tufekci, Sinan, and Hulya Halis. "Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use." THE ULUTAS MEDICAL JOURNAL 7.4 (2021), 248-253. Print. doi:10.5455/umj.20210831071258



APA (American Psychological Association) Style

Tufekci, S. & Halis, . H. (2021) Treatment of Acute Pulmonary Hemorrhage in Neonates with Endotracheal Ankaferd Blood Stopper Use. THE ULUTAS MEDICAL JOURNAL, 7 (4), 248-253. doi:10.5455/umj.20210831071258